You are here

Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing

BioSpace

Fri, 02/1/19 - 11:27 am

Tags:

earnings, Pfizer, Amgen, AbbVie, JNJ, Merck, Novo Nordisk, Takeda

Report: five companies would take brunt of Trump Part B proposal

BioCentury

Fri, 02/1/19 - 11:24 am

Tags:

Donald Trump, Medicare Part B, Amgen, Regeneron, Bristol-Myers Squibb, Genentech, Roche

Even with new competition, Botox can hold its own in growing migraine field: Allergan executives

Fierce Pharma

Thu, 01/31/19 - 11:48 am

Tags:

Allergan, Botox, Amgen, Eli Lilly, Teva Pharmaceuticals, migraines

Calico brings on Amgen’s translational R&D head to lead early drug development

Fierce Biotech

Thu, 01/31/19 - 11:26 am

Tags:

Amgen, R&D, Calico Life Sciences, Alphabet

Amgen hunts for deals of all sizes to combat forthcoming sales decline

Fierce Pharma

Tue, 01/29/19 - 11:17 pm

Tags:

Amgen, earnings, M&A

CVS to cover migraine drugs from Teva, Lilly; excludes Amgen

Reuters

Sat, 01/26/19 - 11:56 am

Tags:

CVS Health, migraines, Amgen, Teva Pharmaceutical, Eli Lilly, Aimovig, Ajovy, Emgality

Pfizer, Novartis, Amgen add to 2019 drug price hikes

Biopharma Dive

Fri, 01/25/19 - 11:03 pm

Tags:

drug pricing, Pfizer, Novartis, Amgen

High-res genetic map by Amgen’s deCODE offers new insight for disease research

Fierce Biotech

Fri, 01/25/19 - 10:21 am

Tags:

Amgen, genomics, deCODE Genetics, genetic map

Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?

Yahoo/Motley Fool

Sun, 01/20/19 - 03:20 pm

Tags:

drug pricing, Big Pharma, Amgen, AstraZeneca, Pfizer, GSK, Merck, Gilead

Amgen's once-dismissed osteoporosis drug Evenity 'back in the game' after rosy FDA panel vote

Fierce Pharma

Thu, 01/17/19 - 12:06 am

Tags:

Amgen, osteoporosis, Evenity, romosozumab, FDA, advisory panels

FDA staff largely unfazed by CV signal in Amgen osteoporosis drug trials

Endpoints

Mon, 01/14/19 - 11:37 pm

Tags:

Amgen, osteoporosis, FDA, romosozumab, clinical trials

Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical

Fierce Pharma

Mon, 01/14/19 - 11:11 am

Tags:

Allergan, Botox, migraines, CGRP blockers, Amgen, Novartis, Aimovig, Teva Pharmaceutical, Ajovy, Eli Lilly, Emgality

NICE turns down Novartis' Aimovig, flagging clinical trial concerns

Biopharma Dive

Fri, 01/11/19 - 08:18 pm

Tags:

NICE, UK, Amgen, Novartis, migraines, Aimovig

Amgen touts lowered prices for Repatha delivery devices

Drug Delivery Business News

Tue, 01/8/19 - 07:20 pm

Tags:

Amgen, drug delivery, Repatha

Could Gilead, Amgen and AbbVie follow Bristol-Myers into megadeal territory?

Fierce Pharma

Sat, 01/5/19 - 01:34 pm

Tags:

M&A, Bristol-Myers Squibb, Celgene, Gilead Sciences, AbbVie, Amgen

Here's Why bluebird bio Shares Got Knocked Down 19.3% in December

Motley Fool

Sat, 01/5/19 - 12:05 am

Tags:

Bluebird Bio, ASH2018, AMG 420, Amgen

Amgen pays $50M for Molecular Partners’ preclinical bispecific

Fierce Biotech

Wed, 12/19/18 - 10:07 am

Tags:

Amgen, Molecular Partners, MP0310

Amgen teams with Entera to develop oral biologics

Fierce Biotech

Wed, 12/12/18 - 12:24 am

Tags:

Amgen, Entera Bio, biologics, drug development

Amgen Contributes to Nonprofit to Support Greater Diversity in Clinical Trials

BioSpace

Wed, 12/12/18 - 12:19 am

Tags:

Amgen, clinical trials, diversity, minorities, oncology

Pages

last 30 twitter posts